Michael Morgan
Overview
Explore the profile of Michael Morgan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
223
Citations
7558
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chiyyeadu A, Asgedom G, Bruhn M, Rocha C, Schlegel T, Neumann T, et al.
Clin Immunol
. 2024 Jan;
260:109902.
PMID: 38218210
The devastating impact of COVID-19 on global health shows the need to increase our pandemic preparedness. Recombinant therapeutic antibodies were successfully used to treat and protect at-risk patients from COVID-19....
12.
Abdin S, Paasch D, Kloos A, Carvalho Oliveira M, Jang M, Ackermann M, et al.
J Immunother Cancer
. 2023 Dec;
11(12).
PMID: 38135346
Background: Macrophages have recently become attractive therapeutics in cancer immunotherapy. The potential of macrophages to infiltrate and influence solid malignancies makes them promising targets for the chimeric antigen receptor (CAR)...
13.
Tung-Hahn E, Mogilevskiy V, Black E, Morgan M, Tung R
Arch Dermatol Res
. 2023 Dec;
316(1):50.
PMID: 38108932
CD30+ lymphoproliferative diseases (LPDs) are relatively uncommon in the general population, especially in children. Distinguishing between the two main CD30+ LPDs, lymphomatoid papulosis and cutaneous anaplastic large-cell lymphoma is crucial,...
14.
Morgan M, Thai J, Nencini S, Xu J, Ivanusic J
Mol Pain
. 2023 Dec;
19:17448069231222407.
PMID: 38073226
STOML3 is a membrane bound scaffolding protein that has been shown to facilitate the opening of mechanically sensitive ion channels and contribute to noxious mechanical sensation, allodynia and hyperalgesia. In...
15.
Alaboudi M, Morgan M, Serra A, Abboud H
Mult Scler Relat Disord
. 2023 Dec;
81:105150.
PMID: 38043365
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently defined demyelinating disorder with a rapidly evolving clinical spectrum. Recently, consensus criteria have been proposed (Banwell et al., 2023) to...
16.
Schambach A, Buchholz C, Torres-Ruiz R, Cichutek K, Morgan M, Trapani I, et al.
Lancet
. 2023 Nov;
403(10426):568-582.
PMID: 38006899
Gene therapy has become a clinical reality as market-approved advanced therapy medicinal products for the treatment of distinct monogenetic diseases and B-cell malignancies. This Therapeutic Review aims to explain how...
17.
Schott J, Huang P, Morgan M, Nelson-Brantley J, Koehler A, Renslo B, et al.
Mol Ther
. 2023 Nov;
31(12):3502-3519.
PMID: 37915173
Usher syndrome 1B (USH1B) is a devastating genetic disorder with congenital deafness, loss of balance, and blindness caused by mutations in the myosin-VIIa (MYO7A) gene, for which there is currently...
18.
Ha T, Morgan M, Schambach A
Signal Transduct Target Ther
. 2023 Sep;
8(1):354.
PMID: 37718346
No abstract available.
19.
Buning H, Morgan M, Schambach A
Signal Transduct Target Ther
. 2023 Sep;
8(1):340.
PMID: 37699901
No abstract available.
20.
Britto M, Siddiq D, Morgan M, Dedea A, Patel U
HCA Healthc J Med
. 2023 Jul;
2(2):101-104.
PMID: 37425645
Introduction: Erythema Induratum (EI) is a relatively rare dermatologic disorder affecting subcutaneous fat tissue, which is often associated with . This report details the presentation, diagnosis and management in a...